The Pathophysiology and Treatment of Sepsis, New England Journal of Medicine, vol.348, issue.2, pp.138-150, 2003. ,
DOI : 10.1056/NEJMra021333
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*, Critical Care Medicine, vol.35, issue.5, pp.1244-1250, 1993. ,
DOI : 10.1097/01.CCM.0000261890.41311.E9
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.1303-1310, 2001. ,
DOI : 10.1097/00003246-200107000-00002
Sepsis in European intensive care units: Results of the SOAP study*, Critical Care Medicine, vol.34, issue.2, pp.344-353, 2006. ,
DOI : 10.1097/01.CCM.0000194725.48928.3A
Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive, American Journal of Respiratory and Critical Care Medicine, vol.163, issue.2, pp.316-321, 2001. ,
DOI : 10.1164/ajrccm.163.2.2007102
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony, Mol Med, vol.14, pp.64-78, 2008. ,
Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis, Critical Care, vol.10, issue.5, p.233, 2006. ,
DOI : 10.1186/cc5055
Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans, The Journal of Immunology, vol.166, issue.11, pp.6952-6963, 2001. ,
DOI : 10.4049/jimmunol.166.11.6952
Increased circulating regulatory T cells (CD4+CD25+CD127???) contribute to lymphocyte anergy in septic shock patients, Intensive Care Medicine, vol.71, issue.4, pp.678-686, 2009. ,
DOI : 10.1007/s00134-008-1337-8
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock, Intensive Care Medicine, vol.51, issue.8, pp.1175-1183, 2006. ,
DOI : 10.1007/s00134-006-0204-8
URL : https://hal.archives-ouvertes.fr/hal-00428008
PD-1 and Its Ligands in Tolerance and Immunity, Annual Review of Immunology, vol.26, issue.1, pp.677-704, 2008. ,
DOI : 10.1146/annurev.immunol.26.021607.090331
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006. ,
DOI : 10.1126/science.274.5284.94
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nature Medicine, vol.168, issue.10, pp.1198-1202, 2006. ,
DOI : 10.1038/nm1482
T cell survival in HIV infection, The Journal of Experimental Medicine, vol.105, issue.10, pp.2281-2292, 2006. ,
DOI : 10.1074/jbc.M300633200
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis, Proceedings of the National Academy of Sciences, vol.106, issue.15, pp.6303-6308, 2009. ,
DOI : 10.1073/pnas.0809422106
Toward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome), JAMA: The Journal of the American Medical Association, vol.268, issue.24, pp.3452-3455, 1992. ,
DOI : 10.1001/jama.1992.03490240060037
Conclusions., Infection Control & Hospital Epidemiology, vol.130, issue.11, pp.1054-1065, 2008. ,
DOI : 10.1097/01.CCM.0000050298.59549.4A
Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock, Clin Chem, vol.48, pp.1589-1592, 2002. ,
The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration, Immunology Letters, vol.95, issue.2, pp.193-198, 2004. ,
DOI : 10.1016/j.imlet.2004.07.009
Programmed death-1???induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection, Nature Medicine, vol.372, issue.10, pp.452-459, 2010. ,
DOI : 10.1038/nm.2106
PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nature Immunology, vol.137, issue.3, pp.261-268, 2001. ,
DOI : 10.1038/85330
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2, European Journal of Immunology, vol.32, issue.3, pp.634-643, 2002. ,
DOI : 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, The Journal of Experimental Medicine, vol.142, issue.7, pp.1027-1034, 2000. ,
DOI : 10.1016/0008-8749(91)90091-O
SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation, The Journal of Immunology, vol.173, issue.2, pp.945-954, 2004. ,
DOI : 10.4049/jimmunol.173.2.945
Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction, Journal of Virology, vol.81, issue.17, pp.9249-9258, 2007. ,
DOI : 10.1128/JVI.00409-07
Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization, Gastroenterology, vol.134, issue.7, pp.1927-1937, 1937. ,
DOI : 10.1053/j.gastro.2008.02.033
PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors, Blood, vol.109, issue.11, pp.4671-4678, 2007. ,
DOI : 10.1182/blood-2006-09-044826
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients, Critical Care, vol.15, issue.1, p.70, 2011. ,
DOI : 10.1097/CCM.0b013e3181ab858a
PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients, Molecular Immunology, vol.45, issue.4, pp.963-970, 2008. ,
DOI : 10.1016/j.molimm.2007.07.038
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction, Critical Care, vol.14, issue.6, p.220, 2010. ,
DOI : 10.1186/cc9354
Negative signaling contributes to T-cell anergy in trauma patients, Critical Care Medicine, vol.35, issue.3, pp.794-801, 2007. ,
DOI : 10.1097/01.CCM.0000256847.61085.A5
Critical Care, p.99, 2011. ,
Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways, Proceedings of the National Academy of Sciences, vol.103, issue.42, pp.15564-15569, 2006. ,
DOI : 10.1073/pnas.0607028103
B and T Lymphocyte Attenuator Tempers Early Infection Immunity, The Journal of Immunology, vol.183, issue.3, pp.1946-1951, 2009. ,
DOI : 10.4049/jimmunol.0801866
Both percentage of ???? T lymphocytes and CD3 expression are reduced during septic shock, Critical Care Medicine, vol.33, issue.12, pp.2836-2840, 2005. ,
DOI : 10.1097/01.CCM.0000189745.66585.AE
Perioperative Gene Expression Analysis for Prediction of Postoperative Sepsis, Clinical Chemistry, vol.56, issue.4, pp.613-622, 2010. ,
DOI : 10.1373/clinchem.2009.133876
Induction of Global Anergy Rather Than Inhibitory Th2 Lymphokines Mediates Posttrauma T Cell Immunodepression, Clinical Immunology, vol.96, issue.1, pp.52-66, 2000. ,
DOI : 10.1006/clim.2000.4879
Immunotherapy for Sepsis ??? A New Approach against an Ancient Foe, New England Journal of Medicine, vol.363, issue.1, pp.87-89, 2010. ,
DOI : 10.1056/NEJMcibr1004371
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, EMBO J, vol.11, pp.3887-3895, 1992. ,
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis, Journal of Leukocyte Biology, vol.88, issue.2, pp.233-240, 2010. ,
DOI : 10.1189/jlb.0110037
Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients, Critical Care, vol.14, issue.4, p.133, 2010. ,
DOI : 10.1186/cc9181
Editorial: PD-1, a new target for sepsis treatment: better late than never, Journal of Leukocyte Biology, vol.88, issue.2, pp.225-226, 2010. ,
DOI : 10.1189/jlb.0410240